Prostate Research Group, Edinburgh Cancer Research Centre, University of Edinburgh, reports in January 2009 Int J Cancer on their team’s efforts to “assess the effects and mechanism of action” of a non steroidal antiflammatory drug (NSAID) called NO-sulindac on the PC-3 prostate cancer cell line under hypoxic conditions.”
Hypoxia is the state in which body [...] (Source: psa-rising.com/blog)

Original post by psa-rising.com/blog and software by Elliott Back

Tho’ much is taken, much abides; and tho’
We are not now that strength which in old days
Moved earth and heaven, that which we are, we are –
One equal temper of heroic hearts,
Made weak by time and fate, but strong in will
To strive, to seek, to find, and not to yield.
– From “Ulysses”
Alfred, Lord Tennyson (Source: psa-rising.com/blog)

Original post by psa-rising.com/blog and software by Elliott Back

Press Release
FDA Approves Drug for Patients with Advanced Prostate Cancer
The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer.
Degarelix is intended to treat patients with advanced prostate cancer. It belongs to a class of agents called gonadotropin releasing hormone (GnRH) receptor inhibitors. These agents slow the growth and progression of prostate cancer by suppressing testosterone, which plays an important role in the continued growth of prostate cancer.
Hormonal treatments for prostate cancer may cause an initial surge in testosterone production before lowering testosterone levels. This initial stimulation of the hormone receptors may temporarily prompt tumor growth rather than inhibiting it. D…

Original post by Cancer Commentary and software by Elliott Back

Below are a graph and a table of the effect of Ferring’s degarelix on testosterone compared with the effect of Lupron. On December 24th Ferring announced that FDA has approved degarelix for the treatment of hormonally sensitive advanced prostate cancer.
The company has yet to announce a brand name for their product (which makes the online [...] (Source: psa-rising.com/blog)

Original post by psa-rising.com/blog and software by Elliott Back

Just 11 months till next Movember! To get in the spirit, check out this Australian video, which explains, the aim of Movember is change the face of men’s health.
Movember in Grandforks, North Dakota, raised $7,000 for prostate cancer research. The money went to the Prostate Cancer Foundation in Santa Monica, Calif. (Source: psa-rising.com/blog)

Original post by psa-rising.com/blog and software by Elliott Back

Just 11 months till next Movember! To get in the spirit, check out this Australian video, which explains, the aim of Movember is change the face of men’s health.
Movember in Grandforks, North Dakota, raised $7,000 for prostate cancer research. The money went to the Prostate Cancer Foundation in Santa Monica, Calif. (Source: psa-rising.com/blog)

Original post by psa-rising.com/blog and software by Elliott Back

Jenny Potter in The North Bay Nugget, Ontario, Canada, reports “Another obstacle is out of the way for men at risk of developing prostate cancer.” Unfortunately, this is not quite yet the case. As Potter says:
The Ontario government recently announced it will cover the cost of the prostate-specific antigen tests when performed at laboratories.
Currently, publicly [...] (Source: psa-rising.com/blog)

Original post by psa-rising.com/blog and software by Elliott Back

I’m not sure why this was studied, but the results are interesting. Apparently if you’re an African-American male who is gay or bisexual, you’re in a group of men that is least likely to go for prostate cancer screening. This finding was published in the recent issue of Medical Care.
Researchers used information gleaned from almost 20,000 telephone interviews with men who participated in a project called the California Interview Survey. While the findings didn’t find a difference between PSA testing (prostate specific antigen) between the orientation of men in general, when the groups were broken down according to race, African-American men showed a big difference between heterosexuals and those who were either gay or bisexual.
African-Americans who were not hetero…

Original post by Cancer Commentary and software by Elliott Back

350 alternative cancer treatments in one book summarized in 5 simple steps:
 
get all the help you can from modern medicine 
add to that any alternative cancer treatments 
have positive attitude 
lead healthy lifestyle 
find relaxation procedures because stress is a killer!
 
My Christmas present and New Years resolution
 
Today I received an ebook in my email : 350 alternative cancer treatments from Karon Beattie. It starts like this:
 
The reason alternative cancer treatments are not more widely known…has little to do with their alleged therapeutic ineffectiveness and far more to do with political control and the therapy marketplace.
 
Now ask yourself: why is so much money be spend on cancer research and just so little re…

Original post by Metastatic liver cancer and software by Elliott Back

There’s good news in the prostate cancer screening world. The results of a study reviewing the compliance and effectiveness of prostate cancer screening among over 150,000 men and women who participated in Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial are very encouraging.
According to the research, published in the December issue of BJU Journal, "Just under five per cent of the men who took part in the prostate cancer element of the USA’s largest ever cancer screening trial were diagnosed with the disease and the majority of those were picked up by screening programmes." From the larger group, 38,349 men were randomly selected at random undergo a blood test for prostate-specific antigen (PSA) test, as well as a digital rectal examination (DRE).
Accord…

Original post by Cancer Commentary and software by Elliott Back

Newer Posts »